Angioimmunoblastic lymphadenopathy with dysproteinemia
- 1 September 1979
- journal article
- research article
- Published by Elsevier in American Journal Of Medicine
- Vol. 67 (3), 421-428
- https://doi.org/10.1016/0002-9343(79)90788-5
Abstract
No abstract availableThis publication has 38 references indexed in Scilit:
- Restoration of Defective Cellular Immunity by Levamisole in a Patient with Immunoblastic LymphadenopathyScandinavian Journal of Haematology, 2009
- SKIN BIOPSY IN ANGIOIMMUNOBLASTIC LYMPHADENOPATHYThe Lancet, 1978
- Variable Phenotypic Expression of an X-Linked Recessive Lymphoproliferative SyndromeNew England Journal of Medicine, 1977
- LEVAMISOLE IN ANGIO-IMMUNOBLASTIC LYMPHADENOPATHYThe Lancet, 1976
- A simple rosette assay for demonstration of complement receptor sites using complement‐coated zymosan beadsEuropean Journal of Immunology, 1975
- Antibody dependent cellular cytotoxicity: Cytotoxicity mediated by non T-lymphocytesClinical Immunology and Immunopathology, 1974
- ANGIO-IMMUNOBLASTIC LYMPHADENOPATHY WITH DYSPROTEINÆMIAThe Lancet, 1974
- IMMUNOGLOBULIN AND GLUCOSE-6-PHOSPHATE DEHYDROGENASE AS MARKERS OF CELLULAR ORIGIN IN BURKITT LYMPHOMAThe Journal of Experimental Medicine, 1973
- SURFACE MARKERS ON HUMAN T AND B LYMPHOCYTESThe Journal of Experimental Medicine, 1972
- Evidence for a clonal origin of head and neck tumorsInternational Journal of Cancer, 1972